Shanghai Fosun Pharmaceutical's controlling shareholder has accumulated an additional 4.295 million A-shares, with the increase holding period expiring.

Shanghai Fosun Pharmaceutical (600196.SH) announced that its controlling shareholder, Shanghai Fosun High Technology (Group) Co., Ltd. ("Fosun High Technology"), has increased its holdings of the company by a total of 4.295 million A-shares through the Shanghai Stock Exchange trading system, accounting for approximately 0.16% of the total number of shares issued by the company as of September 13, 2023. The total amount of the increase in holdings is approximately RMB 101 million. The deadline for the increased holdings plan will expire on September 12, 2024.